These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 28115166)
21. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma. Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649 [TBL] [Abstract][Full Text] [Related]
22. Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells. Imajo M; Kondoh K; Yamamoto T; Nakayama K; Nakajima-Koyama M; Nishida E Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28483913 [TBL] [Abstract][Full Text] [Related]
23. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. Meng S; Chen Z; Munoz-Antonia T; Wu J Biochem J; 2005 Oct; 391(Pt 1):143-51. PubMed ID: 15952937 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression. Hattori T; Sentani K; Naohide O; Sakamoto N; Yasui W Cancer Sci; 2017 Jan; 108(1):143-150. PubMed ID: 27859949 [TBL] [Abstract][Full Text] [Related]
26. Ninjurin 2 overexpression promotes human colorectal cancer cell growth Li G; Zhou LN; Yang H; He X; Duan Y; Wu F Aging (Albany NY); 2019 Oct; 11(19):8526-8541. PubMed ID: 31597121 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of maple syrup on the cell growth and invasion of human colorectal cancer cells. Yamamoto T; Uemura K; Moriyama K; Mitamura K; Taga A Oncol Rep; 2015 Apr; 33(4):1579-84. PubMed ID: 25647359 [TBL] [Abstract][Full Text] [Related]
28. Isorhamnetin suppresses colon cancer cell growth through the PI3K‑Akt‑mTOR pathway. Li C; Yang X; Chen C; Cai S; Hu J Mol Med Rep; 2014 Mar; 9(3):935-40. PubMed ID: 24398569 [TBL] [Abstract][Full Text] [Related]
29. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway. Sun Y; Tian H; Wang L Oncol Rep; 2015 Apr; 33(4):1828-36. PubMed ID: 25683168 [TBL] [Abstract][Full Text] [Related]
30. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways. Huynh N; Liu KH; Baldwin GS; He H Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063 [TBL] [Abstract][Full Text] [Related]
32. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793 [TBL] [Abstract][Full Text] [Related]
33. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734 [TBL] [Abstract][Full Text] [Related]
34. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis]. Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251 [TBL] [Abstract][Full Text] [Related]
35. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression. Lee SC; Kim OH; Lee SK; Kim SJ Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645 [TBL] [Abstract][Full Text] [Related]
36. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway. Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537 [TBL] [Abstract][Full Text] [Related]
37. SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer. Zhang LL; Zhan L; Jin YD; Min ZL; Wei C; Wang Q; Chen YJ; Wu QM; Hu XM; Yuan Q Eur J Pharmacol; 2017 Feb; 797():1-8. PubMed ID: 28088387 [TBL] [Abstract][Full Text] [Related]
38. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling. Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168 [TBL] [Abstract][Full Text] [Related]
39. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer. Kou C; Zhou T; Han X; Zhuang H; Qian H Biochem Biophys Res Commun; 2015 Aug; 464(2):519-25. PubMed ID: 26159916 [TBL] [Abstract][Full Text] [Related]
40. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis. Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]